Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Daglipack M 10mg/1000mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Koye Pharmaceuticals Pvt ltd

Salt Composition

Dapagliflozin (10mg) + Metformin (1000mg)

Overview Daglipack M 10mg/1000mg Tablet ER

Metformin/dapagliflozin extended-release tablets (10mg/1000mg) manage type 2 diabetes by regulating elevated blood glucose. This dual-action medication minimizes the risk of severe diabetic complications, including cardiovascular issues. Administer this medication with food, consistently at the same time daily for optimal adherence. Dosage is determined by your physician; discontinue only under medical supervision, as abrupt cessation can elevate blood sugar, potentially leading to kidney damage or vision loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Common side effects include headache, nausea, vomiting, diarrhea, nasal congestion, sore throat, and rhinorrhea. Hydration is crucial to prevent dehydration. Genital fungal infections are a possibility; practicing good hygiene mitigates this risk. Prior to commencing treatment, disclose any kidney or liver conditions, urinary tract infections, or diuretic use to your doctor. Pregnant or lactating individuals should seek medical advice. Limit alcohol consumption to reduce the likelihood of adverse effects. Regular blood glucose monitoring is essential during treatment.

Uses of Daglipack M 10mg/1000mg Tablet ER

Managing type 2 diabetes

Major Benefits of Daglipack M 10mg/1000mg Tablet ER:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet; do not crush, chew, or fracture it. Daglipack M 10mg/1000mg Extended-Release tablets should be taken with a meal.

Common Side effects of Daglipack M 10mg/1000mg Tablet ER:

  • Nausea
  • Vomiting
  • Diarrhea
  • Genital fungal infection
  • Nasopharyngitis (inflammation of the throat and nasal passages)
  • Urinary tract infection
  • Polyuria
  • Flatulence
  • Skin rash
  • Taste change
  • Difficulty in urination
  • Hypoglycemia (low blood glucose level)
  • Tremors
  • Dizziness
  • Back pain
  • Increased hematocrit
  • Decreased creatinine clearance
  • Dyslipidemia

How to use Daglipack M 10mg/1000mg Tablet ER:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the entire tablet without chewing, crushing, or fracturing. Consume Daglipack M 10mg/1000mg Extended-Release tablets with a meal.

How Daglipack M 10mg/1000mg Tablet ER works:

Extended-release Dapagliflozin/Metformin tablets (Daglipack M 10mg/1000mg) combine two antidiabetic agents to enhance blood glucose management. Dapagliflozin facilitates urinary glucose excretion, while Metformin reduces hepatic glucose production, slows intestinal glucose uptake, and improves insulin sensitivity. This dual action leads to more effective blood sugar regulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Daglipack M 10mg/1000mg Extended-Release Tablets with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Daglipack M 10mg/1000mg tablets might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Daglipack M 10mg/1000mg tablets are likely unsuitable for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Extended-release Daglipack M 10mg/1000mg tablets require careful administration for individuals with impaired kidney function. Dosage modification of Daglipack M 10mg/1000mg extended-release tablets might be necessary. Physician consultation is advised.

LiverLiverCAUTION

Individuals with hepatic impairment should exercise caution when using Daglipack M 10mg/1000mg Extended-Release tablets. Dosage modification of Daglipack M 10mg/1000mg Extended-Release tablets may be necessary. Physician consultation is recommended.

What if you forget to take Daglipack M 10mg/1000mg Tablet ER :

Should you forget a Daglipack M 10mg/1000mg Extended-Release tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Daglipack M 10mg/1000mg Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management
Daglipack M 10mg/1000mg T...
122
MRP 149
18% off